Rituximab,Lenalidomide
Biogen,Roche
['lymphoma', 'lymsm', 'follicular', 'cml']
great to start #17icml with on follicular lymphoma - bm biopsy is largely useless
- pod24 main useful prognostic marker
- some patients likely cured
- r2 an attractive chemo-free option #lymsm 
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem